116 related articles for article (PubMed ID: 32615529)
1. Impact of multiple sclerosis risk loci in postinfectious neurological syndromes.
Martinelli-Boneschi F; Currò R; Santoro S; Berzero G; Sorosina M; Ferrè L; Mascia E; Peroni S; Comi G; Gugliemi A; Vegezzi E; Callegari I; Filippi M; Cortese A; Esposito F; Clarelli F; Marchioni E
Mult Scler Relat Disord; 2020 Sep; 44():102326. PubMed ID: 32615529
[TBL] [Abstract][Full Text] [Related]
2. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.
De Jager PL; Chibnik LB; Cui J; Reischl J; Lehr S; Simon KC; Aubin C; Bauer D; Heubach JF; Sandbrink R; Tyblova M; Lelkova P; ; ; ; ; Havrdova E; Pohl C; Horakova D; Ascherio A; Hafler DA; Karlson EW
Lancet Neurol; 2009 Dec; 8(12):1111-9. PubMed ID: 19879194
[TBL] [Abstract][Full Text] [Related]
3. Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Sorosina M; Brambilla P; Clarelli F; Barizzone N; Lupoli S; Guaschino C; Osiceanu AM; Moiola L; Ghezzi A; Coniglio G; Patti F; Mancardi G; Manunta P; Glorioso N; Guerini FR; Bergamaschi R; Perla F; ; ; Martinelli V; Cusi D; Leone M; Comi G; D'Alfonso S; Martinelli-Boneschi F
Mult Scler; 2014 Jun; 20(7):802-11. PubMed ID: 24277324
[TBL] [Abstract][Full Text] [Related]
4. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
van Pelt ED; Mescheriakova JY; Makhani N; Ketelslegers IA; Neuteboom RF; Kundu S; Broer L; Janssens C; Catsman-Berrevoets CE; van Duijn CM; Banwell B; Bar-Or A; Hintzen RQ
Neurology; 2013 Dec; 81(23):1996-2001. PubMed ID: 24198294
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
Karussis D
J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
[TBL] [Abstract][Full Text] [Related]
7. Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity.
Søndergaard HB; Petersen ER; Magyari M; Sellebjerg F; Oturai AB
Mult Scler Relat Disord; 2017 Apr; 13():25-27. PubMed ID: 28427696
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
Kalincik T; Guttmann CR; Krasensky J; Vaneckova M; Lelkova P; Tyblova M; Seidl Z; De Jager PL; Havrdova E; Horakova D
Genes Immun; 2013 Jun; 14(4):244-8. PubMed ID: 23575354
[TBL] [Abstract][Full Text] [Related]
9. The burden of multiple sclerosis variants in continental Italians and Sardinians.
Barizzone N; Zara I; Sorosina M; Lupoli S; Porcu E; Pitzalis M; Zoledziewska M; Esposito F; Leone M; Mulas A; Cocco E; Ferrigno P; Guerini FR; Brambilla P; Farina G; Murru R; Deidda F; Sanna S; Loi A; Barlassina C; Vecchio D; Zauli A; Clarelli F; Braga D; Poddie F; Cantello R; Martinelli V; Comi G; Frau J; Lorefice L; Pugliatti M; Rosati G; ; Melis M; Marrosu MG; Cusi D; Cucca F; Martinelli Boneschi F; Sanna S; D'Alfonso S
Mult Scler; 2015 Oct; 21(11):1385-95. PubMed ID: 26438306
[TBL] [Abstract][Full Text] [Related]
10. Postinfectious neurologic syndromes: a prospective cohort study.
Marchioni E; Ravaglia S; Montomoli C; Tavazzi E; Minoli L; Baldanti F; Furione M; Alfonsi E; Bergamaschi R; Romani A; Piccolo L; Zardini E; Bastianello S; Pichiecchio A; Ferrante P; Delbue S; Franciotta D; Bono G; Ceroni M
Neurology; 2013 Mar; 80(10):882-9. PubMed ID: 23325908
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
12. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
13. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis.
Sorosina M; Esposito F; Guaschino C; Clarelli F; Barizzone N; Osiceanu AM; Brambilla P; Mascia E; Cavalla P; Gallo P; ; ; Martinelli V; Leone M; Comi G; D'Alfonso S; Martinelli Boneschi F
Mult Scler; 2015 Oct; 21(11):1463-7. PubMed ID: 25533292
[TBL] [Abstract][Full Text] [Related]
15. Clinical and diagnostic features of patients with familial multiple sclerosis.
Andrijauskis D; Balnyte R; Keturkaite I; Vaitkus A
Med Hypotheses; 2019 Oct; 131():109310. PubMed ID: 31443766
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of acute partial transverse myelitis.
Bourre B; Zéphir H; Ongagna JC; Cordonnier C; Collongues N; Debette S; Fleury MC; Outteryck O; Hannequin D; Vermersch P; de Seze J
Arch Neurol; 2012 Mar; 69(3):357-62. PubMed ID: 22410443
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk factors for pediatric-onset multiple sclerosis.
Gianfrancesco MA; Stridh P; Shao X; Rhead B; Graves JS; Chitnis T; Waldman A; Lotze T; Schreiner T; Belman A; Greenberg B; Weinstock-Guttman B; Aaen G; Tillema JM; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee M; Krupp L; Gorman M; Benson L; Rodriguez M; Mar S; Kahn I; Rose J; Roalstad S; Casper TC; Shen L; Quach H; Quach D; Hillert J; Hedstrom A; Olsson T; Kockum I; Alfredsson L; Schaefer C; Barcellos LF; Waubant E;
Mult Scler; 2018 Dec; 24(14):1825-1834. PubMed ID: 28980494
[TBL] [Abstract][Full Text] [Related]
18. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
19. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.
Shawkatová I; Javor J; Párnická Z; Bucová M; Čopíková-Cudráková D; Michalík J; Gmitterová K; Čierny D; Buc M; Ďurmanová V
Folia Microbiol (Praha); 2017 Jul; 62(4):287-293. PubMed ID: 28130760
[TBL] [Abstract][Full Text] [Related]
20. MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.
Agúndez JA; García-Martín E; Martínez C; Benito-León J; Millán-Pascual J; Calleja P; Díaz-Sánchez M; Pisa D; Turpín-Fenoll L; Alonso-Navarro H; Ayuso-Peralta L; Torrecillas D; Plaza-Nieto JF; Jiménez-Jiménez FJ
Hum Immunol; 2013 Dec; 74(12):1705-8. PubMed ID: 23911736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
